Orthopedic Devices Market Revenue to Attain USD 92.42 Bn by 2033

28 Mar 2025

Share :

Table of Content

1. Orthopedic Devices Market Revenue and Trends 2025 to 2033 2. Market Overview 3. Report Highlights  4. Market Trends 5. Regional Insights 6. Orthopedic Devices Market Coverage 7. Market News 8. Orthopedic Devices Market Companies 9. Market Segmentation

Orthopedic Devices Market Revenue and Trends 2025 to 2033

The orthopedic devices market revenue surpassed USD 65.79 billion in 2025 and is predicted to attain around USD 92.42 billion by 2033 with a CAGR of 4.34% during the forecast period. The increasing prevalence of musculoskeletal disorders, rising geriatric population, and advancements in orthopedic technologies are driving market growth.

Market Overview

The orthopedic devices market includes medical implants together with instruments and equipment that serve the diagnosis and treatment of musculoskeletal conditions. Patients widely apply these devices in procedures that include joint replacement, together with fracture fixation, spinal fusion and sports injury procedures. Market growth facilitated by the healthcare providers' start using minimally invasive surgery procedures along with orthopedic implant technological advances and rising healthcare costs. 

As the Indian population ages, it is expected that the prevalence of MSDs, which are a significant cause of physical disability in older adults, notably increase. Such rising health conditions emphasize how important orthopedic devices become for enhancing both medical results and patient quality. Furthermore, the orthopedic devices market demonstrates substantial development due to escalating musculoskeletal illnesses along with ongoing technical improvements.

• According to the report on NIH 2024, the prevalence of musculoskeletal disorders (MSDs) among Indian adults ranges from 7% to 77%, based on research evidence. 

Stakeholders cooperate with the FDA through active engagement to report their XR technology experiences in surgical systems, including robotic-assisted surgical systems, which directly benefits the FDA's regulatory and scientific activities and encourages innovative orthopedic device development. Orthopedic care continues its dedication to including state-of-the-art technology, which seeks to enhance surgical results while reducing healing periods for patients

• The U.S. Food and Drug Administration (FDA) approved various next-generation orthopedic devices in 2024 as a sign of developing technologies in this field. In 2024, the FDA accepted the Xstim Spine Fusion Stimulator through approval as an enhancement tool for spinal fusion operations through its ability to stimulate bone regeneration. 

Report Highlights 

• By type, the joint reconstruction segment accounted for the largest market share due to increasing cases of osteoarthritis and hip and knee replacements. Advancements in 3D printing and robotic-assisted surgeries are further enhancing patient outcomes.
• By end-user, the hospital segment dominated the market in 2024. Increased patient admissions, advanced healthcare infrastructure, and the presence of skilled medical professionals are driving this segment’s growth.

Market Trends

Growing Prevalence of Musculoskeletal Disorders

The increasing number of osteoarthritis, osteoporosis, and spinal disorders cases is expected to drive the demand for orthopedic devices. The rising number of musculoskeletal disorders in patients with osteoarthritis osteoporosis, and spinal conditions drives the interest in orthopedic medical products. 

• The World Health Organization (WHO) 2022 reports that musculoskeletal conditions stand as the top cause of disability worldwide and create about 17% of all disability Years Lived with Disability (YLDs). 

Advancements in Implant Technologies

The revolution of orthopedic surgery occurs through continuous innovations in implant engineering. Recent advances in 3D-printed implants and robotic-assisted surgeries have produced stronger implants that enhance surgical accuracy and speed up patient healing processes. Medical safety and efficiency evaluations for these devices are conducted by the FDA Orthopaedic and Rehabilitation Devices Panel, which consists of orthopedic experts to ensure adherence to rigorous standards. 

• The U.S. Food and Drug Administration (FDA) introduced its first autologous cellularized scaffold for knee cartilage defect repair through approval in 2024, which served as an important advancement in implant science.  

Rising Demand for Minimally Invasive Surgeries

Minimally invasive surgical procedures continue to expand the orthopedic devices market, as the increased patient and surgical demand. A high number of patients, along with surgeons, opt for arthroscopic and robot-assisted surgical procedures, as these procedures enable them to experience shorter hospital visits and quicker healing while reducing their exposure to surgical complications. The FDA gave clearance to the initial orthopedic surgical system with extended reality (XR) integration in 2019, which initiated increased attention to these advanced surgical systems and their effect on user outcomes. The NIBIB operates as a research institution focused on uncovering novel information about medical implant-related immune responses to create long-term biocompatible materials.

Aging Population

Population aging worldwide stimulates more need for orthopedic medical treatments.  Individuals who are age 70 or older experience the greatest disability-adjusted life years (DALYs) from musculoskeletal conditions based on research found in the Journal of Orthopaedic Surgery and Research in 2025. The continuously rising data demonstrates society's urgent requirement for strong orthopedic solutions that tackle health issues experienced by elderly populations.

• The United Nations' World Population Ageing 2023 report forecasts that the 65+ population reach 1.5 billion individuals by 2050, double the current numbers. Population demographics have changed, which creates more frequent musculoskeletal disorders among population groups.

Regional Insights

North America is projected to maintain its leadership in the orthopedic devices market due to well-established healthcare infrastructure, high adoption of advanced orthopedic technologies, and increasing healthcare expenditure. The market benefits from key market participants while obtaining regulatory backing from the U.S. Food and Drug Administration (FDA). The FDA authorized multiple advanced orthopedic devices, which expanded medical treatment possibilities for patients. The Orthopaedic and Rehabilitation Devices Panel of the FDA comprises orthopedic surgery professionals who determine the safety and effectiveness standards for these devices during evaluations. 

Asia Pacific is anticipated to experience the fastest growth due to expanding healthcare facilities, growing medical tourism, and an increasing burden of orthopedic disorders. Medical device accessibility improvement serves as the main focus of WHO's Global Atlas of Medical Devices while the region works toward improved healthcare results. The WHO's resolution on assistive technology contributes to the orthopedic devices market expansion in the region, according to recent projections.

Orthopedic Devices Market Coverage

Market News

• In February 2024, the American Academy of Orthopaedic Surgeons (AAOS) awarded CytexOrtho as the winner of the inaugural OrthoPitch Technology Competition at the AAOS 2024 Annual Meeting in San Francisco. This initiative promotes innovation to enhance orthopedic care standards.
• In May 2023, Stryker launched the Ortho Q Guidance system, which facilitates advanced surgical planning and guidance for hip and knee procedures controlled by the surgeon from the sterile field. It features new optical tracking and enhanced algorithms for improved workflow efficiency.
• In October 2024, Globus received FDA 510(k) clearance for its TENSOR Suture Button System and launched multiple next-generation systems, including ANTHEM II Distal Radius Volar Plates and AUTOBAHN Trochanteric Nail PRO Instruments.
• In January 2023, Orthofix Medical Inc. announced the full commercial launch of the Mariner Deformity Pedicle Screw System, designed for complex adult spine deformities. This launch includes advanced instrumentation and implant technologies for effective surgical interventions.

Orthopedic Devices Market Companies

• Medacta
• DePuySynthes
• Smith & Nephew
• Stryker
• Medtronic
• Zimmer Biomet
• MicroPort Scientific Corporation (Wright Medical Group)
• DJO Global
• ConforMIS
• NuVasive
• Globus Medical

Market Segmentation

By Product Type

• Joint Reconstruction
  
  • Knee Replacement
    
    • Revision Knee Replacement Implants
    • Total Knee Replacement Implant
    • Partial Knee Replacement Implant
  • Elbow & Shoulder Replacement
• Hip Replacement
  
  • Hip Resurfacing Implant
    
    • Total Hip Replacement Implant
    • Partial Hip Replacement Implant
    • Revision Hip Replacement Implant
• Others
• Orthopedic Prosthetics
  
  • Upper Extremity Orthopedic Prosthetics
  • Lower Extremity Orthopedic Prosthetics
• Spinal Devices
  
  • Spinal Non-fusion Devices
  • Spinal Fusion Devices
• Trauma Fixation
  
  • Nails and Rods
  • Metal Plates & Screws
  • Pins/Wires
  • Others
• Arthroscopy Devices
• Orthopedic Accessories
  
  • Removal systems
  • Bone cement
  • Casting system
• Orthopedic Braces and Supports
  
  • Upper Extremity Braces and Supports
  • Low Extremity Braces and Supports
• Others

By End-user

• Ambulatory Surgical Centers
• Hospitals
• Orthopedic Clinics
• Others

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview
@ https://www.precedenceresearch.com/sample/1027 

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|| +1 804 441 9344